Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

To promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. The Big Pharma has recruited Gabrielle Union-Wade to serve as a celebrity endorser for the ...

Jan 13 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers imposing a 100% tariff on imported branded and patented medicines ...